Open Access548 A RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, ACTIVE CONTROLLED MULTI-CENTER CLINICAL TRIAL TO EVALUATE THE ADDITIONAL EFFICACY AND SAFETY OF OLMESARTAN MEDOXOMIL/AMLODIPINE 20/5 MG IN CHINESE PATIENTS WITH MILD OR MODERATE ESSENTIAL HYPERTENSION WHO FAILED TO ACHIEVE THEIR GOAL WITH AMLODIPINE 5MG MONOTHERAPY
Author(s) -
Pingjin Gao,
Jianhong Zhu
Publication year - 2012
Publication title -
journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.249
H-Index - 172
eISSN - 1473-5598
pISSN - 0263-6352
DOI - 10.1097/01.hjh.0000420822.48472.89
Subject(s) - amlodipine , olmesartan , medicine , blood pressure , placebo , adverse effect , urology , randomized controlled trial , pharmacology , single center , double blind , alternative medicine , pathology